These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 30031228)

  • 1. LAZ3 protects cardiac remodeling in diabetic cardiomyopathy via regulating miR-21/PPARa signaling.
    Gao L; Liu Y; Guo S; Xiao L; Wu L; Wang Z; Liang C; Yao R; Zhang Y
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3322-3338. PubMed ID: 30031228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice.
    Yu M; Liu Y; Zhang B; Shi Y; Cui L; Zhao X
    Cardiovasc Pathol; 2015; 24(6):375-81. PubMed ID: 26164195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-30c/PGC-1β protects against diabetic cardiomyopathy via PPARα.
    Yin Z; Zhao Y; He M; Li H; Fan J; Nie X; Yan M; Chen C; Wang DW
    Cardiovasc Diabetol; 2019 Jan; 18(1):7. PubMed ID: 30635067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Aza resveratrol-chalcone derivative 6b protects mice against diabetic cardiomyopathy by alleviating inflammation and oxidative stress.
    You S; Qian J; Sun C; Zhang H; Ye S; Chen T; Xu Z; Wang J; Huang W; Liang G
    J Cell Mol Med; 2018 Mar; 22(3):1931-1943. PubMed ID: 29327811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of miR-22 attenuates oxidative stress injury in diabetic cardiomyopathy via Sirt 1.
    Tang Q; Len Q; Liu Z; Wang W
    Cardiovasc Ther; 2018 Apr; 36(2):. PubMed ID: 29288528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KLF9 Aggravates Streptozotocin-Induced Diabetic Cardiomyopathy by Inhibiting PPARγ/NRF2 Signalling.
    Li F; Peng J; Feng H; Yang Y; Gao J; Liu C; Xu J; Zhao Y; Pan S; Wang Y; Xu L; Qian W; Zong J
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.
    Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C
    Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AAV9-Mediated Cardiac CNTF Overexpression Exacerbated Adverse Cardiac Remodeling in Streptozotocin-Induced Type 1 Diabetic Models.
    Zhong P; Peng J; Liu T; Ding HS
    Cardiovasc Toxicol; 2022 Jan; 22(1):88-96. PubMed ID: 34674150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-mobility group AT-hook 1 promotes cardiac dysfunction in diabetic cardiomyopathy via autophagy inhibition.
    Wu QQ; Liu C; Cai Z; Xie Q; Hu T; Duan M; Wu H; Yuan Y; Tang Q
    Cell Death Dis; 2020 Mar; 11(3):160. PubMed ID: 32123163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-20a-5p overexpression prevented diabetic cardiomyopathy via inhibition of cardiomyocyte apoptosis, hypertrophy, fibrosis and JNK/NF-κB signalling pathway.
    Liu X; Guo B; Zhang W; Ma B; Li Y
    J Biochem; 2021 Oct; 170(3):349-362. PubMed ID: 33837411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of nuclear β-catenin/c-Myc axis promotes oxidative stress injury in streptozotocin-induced diabetic cardiomyopathy.
    Liu P; Su J; Song X; Wang S
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1573-1580. PubMed ID: 28989026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydromyricetin Prevents Diabetic Cardiomyopathy via miR-34a Suppression by Activating Autophagy.
    Ni T; Lin N; Lu W; Sun Z; Lin H; Chi J; Guo H
    Cardiovasc Drugs Ther; 2020 Jun; 34(3):291-301. PubMed ID: 32212062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. USP28 Serves as a Key Suppressor of Mitochondrial Morphofunctional Defects and Cardiac Dysfunction in the Diabetic Heart.
    Xie SY; Liu SQ; Zhang T; Shi WK; Xing Y; Fang WX; Zhang M; Chen MY; Xu SC; Fan MQ; Li LL; Zhang H; Zhao N; Zeng ZX; Chen S; Zeng XF; Deng W; Tang QZ
    Circulation; 2024 Feb; 149(9):684-706. PubMed ID: 37994595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The protective effects of endogenous hydrogen sulfide modulator, S-propargyl-cysteine, on high glucose-induced apoptosis in cardiomyocytes: A novel mechanism mediated by the activation of Nrf2.
    Yang H; Mao Y; Tan B; Luo S; Zhu Y
    Eur J Pharmacol; 2015 Aug; 761():135-43. PubMed ID: 25979858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Klotho protects the heart from hyperglycemia-induced injury by inactivating ROS and NF-κB-mediated inflammation both in vitro and in vivo.
    Guo Y; Zhuang X; Huang Z; Zou J; Yang D; Hu X; Du Z; Wang L; Liao X
    Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):238-251. PubMed ID: 28982613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses.
    Li L; Luo W; Qian Y; Zhu W; Qian J; Li J; Jin Y; Xu X; Liang G
    Phytomedicine; 2019 Jun; 59():152774. PubMed ID: 31009852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin.
    Dai B; Li H; Fan J; Zhao Y; Yin Z; Nie X; Wang DW; Chen C
    Cardiovasc Diabetol; 2018 Sep; 17(1):123. PubMed ID: 30180843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Si-Miao-Yong-An decoction preserves cardiac function and regulates GLC/AMPK/NF-κB and GLC/PPARα/PGC-1α pathways in diabetic mice.
    Li L; Chen X; Su C; Wang Q; Li R; Jiao W; Luo H; Tian Y; Tang J; Li X; Liu B; Wang W; Zhang D; Guo S
    Biomed Pharmacother; 2020 Dec; 132():110817. PubMed ID: 33068937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FBXL10 regulates cardiac dysfunction in diabetic cardiomyopathy via the PKC β2 pathway.
    Yin L; Fang Y; Song T; Lv D; Wang Z; Zhu L; Zhao Z; Yin X
    J Cell Mol Med; 2019 Apr; 23(4):2558-2567. PubMed ID: 30701683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TAX1BP1 overexpression attenuates cardiac dysfunction and remodeling in STZ-induced diabetic cardiomyopathy in mice by regulating autophagy.
    Xiao Y; Wu QQ; Duan MX; Liu C; Yuan Y; Yang Z; Liao HH; Fan D; Tang QZ
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1728-1743. PubMed ID: 29476905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.